Literature DB >> 11095586

Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid.

G Lin1, Y Y Cui, E M Hawes.   

Abstract

The metabolism of the hepatotoxic otonecine-type pyrrolizidine alkaloid (PA), clivorine, was investigated using rat liver microsomes. The metabolites dehydroretronecine (DHR), 7-glutathionyldehydroretronecine (7-GSH-DHR), 7, 9-diglutathionyldehydroretronecine (7,9-diGSH-DHR), and clivoric acid were identified using chromatographic and mass spectrometric analyses. NMR characterizations were also performed on the isolated clivoric acid and the synthetic 7-GSH-DHR and 7,9-diGSH-DHR. The results indicated that the two glutathione (GSH) conjugates were formed by reaction of the unstable toxic pyrrolic ester with GSH added in the microsomal incubation system, whereas DHR was generated from hydrolysis of the unstable pyrrolic ester, and that clivoric acid was produced from all these further conversions of the unstable pyrrolic ester. Furthermore, tissue-bound pyrroles were also determined to be present after microsomal incubation of clivorine. Clivoric acid has not been previously identified, and DHR and 7, 9-diGSH-DHR were found, for the first time, as metabolites of an otonecine-type PA, while 7-GSH-DHR was previously reported by us to be a microsomal metabolite of clivorine. The in vitro metabolic pathway of clivorine was delineated to be the initial formation of the unstable pyrrolic ester, which then may undergo hydrolysis, GSH conjugations, or covalent binding with hepatic tissues that may lead to hepatotoxicity. The present definitive identification of four pyrrolic ester-related metabolites of clivorine and indirect determination of bound pyrroles provide the strongest evidence to date to support the hypothesis that the formation of an unstable pyrrolic ester plays a key role in otonecine-type PA-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095586

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Metabolism, genotoxicity, and carcinogenicity of comfrey.

Authors:  Nan Mei; Lei Guo; Peter P Fu; James C Fuscoe; Yang Luan; Tao Chen
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-10       Impact factor: 6.393

2.  Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity.

Authors:  Jiang Ma; Chunyuan Zhang; Yisheng He; Xinmeng Chen; Ge Lin
Journal:  Arch Toxicol       Date:  2021-11-18       Impact factor: 5.153

3.  Genotoxicity of pyrrolizidine alkaloids in metabolically inactive human cervical cancer HeLa cells co-cultured with human hepatoma HepG2 cells.

Authors:  Naji Said Aboud Hadi; Ezgi Eyluel Bankoglu; Helga Stopper
Journal:  Arch Toxicol       Date:  2022-10-23       Impact factor: 6.168

4.  Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.

Authors:  Lin Zhu; Chunyuan Zhang; Wei Zhang; Qingsu Xia; Jiang Ma; Xin He; Yisheng He; Peter P Fu; Wei Jia; Yuzheng Zhuge; Ge Lin
Journal:  Arch Toxicol       Date:  2021-08-14       Impact factor: 6.168

5.  Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice.

Authors:  Jun Yao; Cheng-gang Li; Li-kun Gong; Chen-chen Feng; Chun-zhu Li; Man Gao; Yang Luan; Xin-ming Qi; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

Review 6.  Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.

Authors:  Yisheng He; Lin Zhu; Jiang Ma; Ge Lin
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

Review 7.  Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.

Authors:  Xiao-Qian Yang; Jin Ye; Xin Li; Qian Li; Yu-Hu Song
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

8.  Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.

Authors:  Zhangting Wang; Jiang Ma; Sheng Yao; Yisheng He; Kai-Kei Miu; Qingsu Xia; Peter P Fu; Yang Ye; Ge Lin
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

9.  Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.

Authors:  Minjie Jiang; Luyuan Wang; Xiaodong Du; Miaomiao Hao; Pujun Gao
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

10.  Synthesis and phototoxicity of isomeric 7,9-diglutathione pyrrole adducts: Formation of reactive oxygen species and induction of lipid peroxidation.

Authors:  Liang Ma; Hengqiang Zhao; Qingsu Xia; Lining Cai; Peter P Fu
Journal:  J Food Drug Anal       Date:  2015-07-02       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.